Zongyuan Hong
Wuhu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Correction: Specific MAPK inhibitors prevent hyperglycemia-induced renal diseases in type 1 diabetic mouse model.
Journal: Molecular and cellular biochemistry
Published: July 21, 2026
TRIM17 downregulation modulates CRPC progression and enzalutamide resistance by derepressing BCL2 expression via the p53-dependent and p53-independent pathways.
Journal: Cell death and differentiation
Published: July 21, 2025
IKBKE regulates renal cell carcinoma progression and sunitinib resistance through the RRM2-AKT pathway.
Journal: International journal of biological sciences
Published: August 22, 2024
Roles of CDK12 mutations in PCa development and treatment.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: July 14, 2024
MYO6 contributes to tumor progression and enzalutamide resistance in castration-resistant prostate cancer by activating the focal adhesion signaling pathway.
Journal: Cell communication and signaling : CCS
Published: June 18, 2024
Sephin1 enhances integrated stress response and autophagy to alleviate myocardial ischemia-reperfusion injury in mice.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 13, 2024
Network Pharmacology and Intestinal Microbiota Analysis Revealing the Mechanism of Punicalagin Improving Bacterial Enteritis.
Journal: Current computer-aided drug design
Published: September 13, 2022
Intestinal microbiota analysis and network pharmacology reveal the mechanism by which Lianhua Qingwen capsule improves the immune function of mice infected with influenza A virus.
Journal: Frontiers in microbiology
Published: September 03, 2022
Histone acetyltransferase 1 upregulates androgen receptor expression to modulate CRPC cell resistance to enzalutamide.
Journal: Clinical and translational medicine
Published: March 16, 2021
Last Updated: 09/26/2026